YOLFTbeta
Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG

SANN · SW · Healthcare / Biotechnology

14.62CHF-0.48 (-3.18%)

Price History

Full chart

Market Stats

Previous Close15.10
Open15.02
Day Range14.60 – 15.02
52-Week Range9.38 – 18.84
Volume39.18K
Market Cap231.63M
P/E (TTM)0.00
Forward P/E20.88
EPS-2.24
Dividend Yield0.00%
Beta-0.27
50-Day Avg15.55
200-Day Avg15.38

About

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Orlando Oliveira
  • Employees93
  • HeadquartersHohenrainstrasse 24, Pratteln, Switzerland, 4133, Switzerland
  • Websitehttps://www.santhera.com

Leadership

  • Dr. Thomas Meier Ph.D.Founder & Chairman · b. 1962
  • Dr. Shabir Hasham M.D.Chief Medical Officer · b. 1970
  • Mr. Orlando OliveiraChief Executive Officer · b. 1976
  • Ms. Catherine Ann Isted A.C.M.A.Chief Financial Officer · b. 1975
  • Mr. Marc SchraderChief Technology Officer · b. 1971
  • Mr. Oliver StrubHead of Compliance · b. 1963
  • Dr. Oliver P. Kronenberg Ph.D.Chief Legal Officer & Corporate Secretary · b. 1968
  • Mr. Neville Kodkani M.D.Head of Global Marketing & Partner Management
  • Ms. Sarah Holmes-KlotzGlobal Head of People & Culture
  • Mr. Andreas MissyExecutive Vice President of Corporate Planning & Business Development

Financials

Income Statement

Currency: CHF2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue781.00K9.23M48.00K1.64M20.61M3.27M3.54M1.32M2.59M4.32M19.03M22.94M31.66M75.38M15.01M-1.59M7.47M103.41M39.12M77.19M
Growth (%)-+1081.31%-99.48%+3322.92%+1154.35%-84.16%+8.36%-62.72%+96.44%+66.77%+340.48%+20.54%+37.98%+138.10%-80.09%-110.63%+568.53%+1283.84%-62.17%+97.32%
Cost of Revenue--23.00K244.00K378.00K338.00K349.00K140.00K199.00K1.37M3.88M4.10M4.70M5.45M10.43M3.77M3.59M3.23M15.53M62.72M
Gross Profit781.00K9.23M25.00K1.40M20.23M2.93M3.19M1.18M2.39M2.95M15.15M18.84M26.95M69.93M4.58M-5.36M3.88M100.18M22.96M14.47M
Gross Margin100.00%100.00%52.08%85.15%98.17%89.65%90.14%89.39%92.32%68.27%79.60%82.11%85.15%92.77%30.50%336.18%51.93%96.87%58.69%18.74%
Operating Expense29.42M40.35M45.62M47.99M28.94M30.14M34.34M8.49M9.91M-223.00K48.28M69.29M78.38M80.37M57.65M51.53M55.86M31.34M56.34M52.28M
Operating Income-28.64M-31.13M-45.59M-46.59M-8.71M-27.21M-31.16M-7.31M-7.52M3.17M-33.13M-50.45M-51.42M-10.44M-53.08M-56.89M-51.98M68.84M-33.38M-37.82M
Operating Margin-3666.97%-337.38%-94981.25%-2835.73%-42.27%-833.48%-880.58%-554.13%-290.12%73.43%-174.05%-219.91%-162.43%-13.85%-353.65%3566.65%-695.52%66.57%-85.34%-48.99%
EBITDA-26.58M-27.62M-39.07M-20.95M-2.50M-22.48M-11.09M-5.69M-7.87M4.06M-29.92M-44.05M-45.62M-7.54M-53.43M-34.57M-46.78M79.17M-15.89M-32.13M
EBITDA Margin-3402.82%-299.33%-81400.00%-1275.41%-12.11%-688.64%-313.48%-431.08%-303.71%93.87%-157.20%-192.00%-144.11%-10.00%-356.00%2167.40%-625.97%76.56%-40.62%-41.62%
Net Income-28.26M-27.87M-44.66M25.92M-11.26M-27.84M-31.45M-5.75M-7.53M5.95M-35.41M-51.53M-54.19M-18.97M-67.66M-55.53M-71.08M54.78M-41.97M-49.24M
Net Income Margin-3618.18%-302.09%-93033.33%1577.78%-54.62%-852.62%-888.86%-436.32%-290.78%137.68%-186.07%-224.61%-171.17%-25.17%-450.82%3481.25%-951.10%52.97%-107.30%-63.79%
R&D11.02M15.53M31.47M31.54M15.69M18.13M28.72M4.71M5.70M10.45M17.68M26.56M38.24M41.24M34.23M29.71M30.54M18.67M26.47M22.22M
R&D as % of Total Revenue1410.76%168.29%65556.25%1919.42%76.13%555.13%811.87%357.01%219.80%241.91%92.87%115.77%120.79%54.72%228.07%-1863.01%408.62%18.06%67.66%28.79%
Interest Expense231.00K99.00K4.94M3.60M7.45M3.67M125.00K21.00K7.00K11.00K15.00K3.84M4.50M6.08M6.89M16.42M20.19M21.31M20.17M11.56M
Interest Expense % of Total Revenue29.58%1.07%10289.58%219.35%36.17%112.25%3.53%1.59%0.27%0.25%0.08%16.75%14.22%8.07%45.92%-1029.66%270.16%20.61%51.56%14.97%

Balance Sheet

Currency: CHF2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets162.39M144.18M112.95M94.70M78.77M52.03M18.29M9.74M22.95M117.15M90.79M109.78M110.29M115.05M88.69M91.12M63.73M109.63M152.49M148.09M
Total Liabilities10.35M8.66M8.47M11.19M9.14M9.05M6.55M2.63M5.71M10.90M16.44M77.52M82.47M93.80M95.04M89.79M107.41M49.69M124.79M159.90M
Total Equity152.05M135.51M104.47M83.51M69.63M42.98M11.73M7.11M17.24M106.25M74.35M32.26M27.83M21.25M-6.35M1.33M-43.69M59.94M27.70M-11.82M
Cash125.66M106.62M75.01M53.32M43.68M23.41M12.28M5.04M17.43M76.86M49.81M45.20M21.97M31.36M12.41M21.21M1.35M30.37M40.92M22.44M
Total Debt1.42M---2.27M2.24M2.21M----53.11M54.57M65.37M71.17M42.98M44.44M23.03M41.17M97.77M
Net Debt-124.25M-106.62M-75.01M-53.32M-41.41M-21.16M-10.08M-5.04M-17.43M-76.86M-49.81M7.92M32.60M34.01M58.76M21.77M43.08M-7.34M248.00K75.33M

Cash Flow

Currency: CHF2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-24.83M-22.37M-45.69M-20.75M-6.64M-19.89M-11.04M-6.98M-6.06M-22.39M-27.14M-39.63M-37.87M2.60M-43.51M-37.36M-29.84M47.27M-35.53M-34.76M
Investing Cash Flow-283.00K4.39M-793.00K-989.00K-258.00K-66.00K-33.00K272.00K-207.00K-619.00K-459.00K-22.24M-5.91M2.79M1.56M69.00K-3.93M-18.04M-61.00K-122.00K
Financing Cash Flow119.32M-1.39M15.01M24.00K-26.00K21.00K-32.00K-531.00K18.66M82.63M631.00K57.11M20.64M4.13M23.15M46.02M13.99M-171.00K46.08M16.38M
Capital Expenditure1.19M555.00K891.00K989.00K86.00K89.00K32.00K4.00K207.00K515.00K375.00K1.40M21.64M229.00K34.00K15.00K3.96M23.74M151.00K52.00K
Free Cash Flow-26.02M-22.93M-46.58M-21.74M-6.72M-19.98M-11.07M-6.98M-6.27M-22.91M-27.51M-41.03M-59.51M2.37M-43.54M-37.37M-33.80M23.53M-35.68M-34.81M
Dividends Paid--------------24.56M32.66M----
FCF to OCF104.79%102.48%101.95%104.77%101.30%100.45%100.29%100.06%103.41%102.30%101.38%103.52%157.16%91.18%100.08%100.04%113.26%49.77%100.43%100.15%
Dividend Paid to FCF---------------56.40%-87.40%----

Earnings

Report DateApr 11, 2016Sep 6, 2016Nov 11, 2016Mar 7, 2017May 31, 2017Sep 5, 2017Nov 10, 2017Mar 20, 2018May 30, 2018Sep 4, 2018Dec 12, 2018Apr 29, 2019Sep 3, 2019Dec 11, 2019Mar 24, 2020Jun 3, 2020Sep 8, 2020Dec 9, 2020Apr 29, 2021Sep 20, 2021Dec 15, 2021Jun 1, 2022Sep 29, 2022Nov 7, 2022Mar 29, 2023Jun 20, 2023Sep 7, 2023Dec 13, 2023Apr 25, 2024Sep 12, 2024Dec 11, 2024Dec 31, 2024Apr 29, 2025Sep 10, 2025Dec 10, 2025Dec 31, 2025
EPS Estimate-4.90-1.420.00-2.510.00-0.910.00-2.300.000.000.000.000.000.000.000.000.000.000.000.000.00-2.30-0.20-0.20-0.15-0.14-0.14-1.31-1.18-0.94-0.90-0.83-0.83-0.60-0.260.94
EPS Actual-2.80-2.870.00-2.780.00-3.62-1.69-4.600.00-4.25-4.25-3.65-2.470.000.740.000.740.00-2.30-0.920.00-2.30-0.20-0.200.00-1.30-1.58-1.31-1.38-1.35-0.90--2.34-0.60-0.37-
Surprise42.86%-102.11%--10.76%--297.80%--100.00%-------------0.00%0.00%0.00%100.00%-828.57%-1028.57%0.00%-16.95%-43.62%0.00%--181.93%0.00%-42.31%-
TimingAfter-hours---------------------Pre-marketPre-marketPre-marketAfter-hoursPre-market-Pre-market----Pre-market--

Key Statistics & Ratios

Market Cap231.63M
Enterprise Value262.35M
Trailing P/E0.00
Forward P/E20.88
PEG Ratio0.00
Price / Sales2.28
Price / Book6.56
EPS-2.24
Book Value-0.882
Revenue (TTM)101.50M
Gross Profit (TTM)41.60M
EBITDA-3.64M
Profit Margin-31.46%
Operating Margin-13.58%
Return on Equity-620.02%
Return on Assets-3.93%
Shares Outstanding15.32M
Shares Float12.09M
Beta-0.27
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 3, 20231:10